Marrone Bio Innovations, Inc. (MBII) Financial Analysis & Valuation | Quarter Chart
Marrone Bio Innovations, Inc. (MBII)
MBIIPrice: $0.8
Fair Value: 🔒
🔒score
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection, crop health, and crop nutrition. Its products include Emergen, Foramin, Foramin ST, Optima, Takla, Pacesetter, Ympact, UBP, and UBP ST for increasing crop health, yield, and quality; Grandevo, a bio... more
Marrone Bio Innovations, Inc. discovers, develops, and sells biological products for crop protection... more
Description
Shares
| Market Cap | $0 | Exchange | NASDAQ |
| Sector | Basic Materials | Industry | Agricultural Inputs |
| Country | US | CEO | Pamela G. Marrone |
| IPO Date | 2013-08-02 | CAGR | 0.24% |
| Employees | 153 | Website | www.marronebio.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | — | Total Yield | — |
MBII chart loading...
Fundamentals
Technicals
| Enterprise Value | $222.94M | P/E Ratio | -6.82 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | — | P/B Ratio | 4.71 |
| P/CF Ratio | -14.01 | P/FCF Ratio | — |
| EPS | $-0.12 | EPS Growth 1Y | — |
| EPS Growth 3Y | — | EPS Growth 5Y | — |
| Revenue Growth 1Y | 38.03% | Gross Margin | 0.61% |
| Operating Margin | -0.34% | Profit Margin | -0.37% |
| ROE | -0.54% | ROA | -0.19% |
| ROCE | -0.36% | Current Ratio | 0.94 |
| Quick Ratio | 0.75 | Cash Ratio | 0.43 |
| Debt/Equity | 1.26 | Interest Coverage | -9.52 |
| Altman Z Score | — | Piotroski Score | — |